Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 507 across all filing types
Latest filing 2020-05-04 M&A Activity
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항
M&A Activity Classification · 95% confidence The document is a regulatory filing from the Korean company 'OliPass' regarding the termination of a strategic joint research and development contract. It details the counterparty, the nature of the contract, the reason for termination, and the financial impact. Since this is a specific corporate announcement regarding a material business event (contract termination) that does not fit into categories like M&A, dividends, or share transactions, it is classified as a general regulatory filing.
2020-05-04 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Olipass Co., Ltd. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It covers the fiscal year ending December 31, 2019. While it contains financial data, it is the formal audit report rather than a standalone annual report (10-K) or a simple earnings release. Therefore, it is classified as an Audit Report. FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and board/auditor compensation. This aligns perfectly with the definition of a Declaration of Voting Results (DVA), which reports the official outcomes of shareholder votes at a general meeting.
2020-03-26 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of shares, and the underlying reasons (market price decline). This falls under capital structure changes and financing updates, specifically related to convertible securities adjustments, which is best categorized as CAP (Capital/Financing Update).
2020-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It contains the auditor's opinion (적정 - Unqualified), financial highlights (assets, liabilities, equity, profit/loss), and specific regulatory disclosures regarding capital impairment and operating losses. While it contains financial data, it is a regulatory filing announcing the receipt and submission of the audit report, which is a standard requirement for listed companies in Korea. It fits the 'Audit Report / Information' category as it provides the audit opinion and key financial data extracted from the audit. FY 2019
2020-03-17 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Olipass Corporation. It details the meeting date, location, agenda items (such as approval of financial statements, director remuneration, etc.), and provides management's business overview and governance information (board activities). This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming Annual General Meeting (AGM) and to solicit their participation/votes. In the context of the provided categories, this fits the definition of a Proxy Solicitation & Information Statement.
2020-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.